This is the first of a series of posts looking at the main points of contention so far at Committee Stage in the House of Lords for the Medicines and Medical Devices Bill 2019-20. [Part 2 available here] The second session of the Lords Committee Stage on the Medicines and Medical Devices Bill starts today … Continue reading “Lords take Government to task over future of medicines and medical devices regulation: Part I”
Category: Medicines and Medical Devices Bill
Beyond Brexit: Smart Regulation for Investment and Patient Safety
The shape of the post-Brexit regulatory landscape has been the subject of much discussion in recent months. With the end of the transition period looming and the Government remaining scant on details, many academics and stakeholders have been exploring the possibilities. Reform, a Westminster think tank for public service reform, invited Dr Laura Downey, Dr … Continue reading “Beyond Brexit: Smart Regulation for Investment and Patient Safety”
Briefing note: Medicines and Medical Devices Bill (July update)
Originally posted here. Executive summary Patient and user safety with regards to medical devices is paramount. This should be prioritised in situations where there are competing considerations such as “attractiveness of the UK” as to the conduct of clinical trials and supply of medicines and medical devices. The existing regulatory framework for medicines and medical … Continue reading “Briefing note: Medicines and Medical Devices Bill (July update)”
Written evidence: We shouldn’t rush the Medicines and Medical Devices Bill
Although the Medicines and Medical Devices Bill received its first reading in the House of Commons on the 13th of February, progress on the Bill was interrupted by the Covid-19 crisis in March 2020. The Bill has since been re-introduced, passing quickly through the House of Commons. Professor Muireann Quigley, Professor Jean McHale, Dr Rachael … Continue reading “Written evidence: We shouldn’t rush the Medicines and Medical Devices Bill”
Medicines and Medical Devices Bill 2019-20: Patient safety must be the priority
This piece was originally posted on the Birmingham Law School news page. The committee stage of the Medicines and Medical Devices Bill 2019-20 resumed this week. The government has brought forward this new legislation to regulate medicines and medical devices following Brexit. Progress on the Bill paused in March 2020 due to the Covid-19 crisis, … Continue reading “Medicines and Medical Devices Bill 2019-20: Patient safety must be the priority”
Briefing note: How we can improve the Medicines and Medical Devices Bill?
Currently, a large part of the UK’s regulatory regime governing medicines and medical devices is derived from EU law. The Medicines and Medical Devices Bill (MMDB) 2019-20 sets out a suite of provisions for the regulation of medicines and medical devices in the UK at the end of the EU exit transition period, currently 31 … Continue reading “Briefing note: How we can improve the Medicines and Medical Devices Bill?”